Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Orakl Oncology Logo
Orakl Oncology Growth Score
63
CB Rank
24505
Heat Score
19
Orakl Oncology is a precision oncology company that combines data and biology to bring new drugs to cancer patients.
Founded
obfuscation
PrivateNon-equity Assistance Villejuif, Ile-de-France, France1-10 www.orakl-oncology.com
Biotechnology
Medical
Oncology
Therapeutics
Overview

Orakl Oncology
Total Funding
obfuscation
Growth Score
63
Heat Score
19

Total Funding
obfuscation
obfuscation
Non-equity Assistance raised
obfuscation
Growth Score63
-7 pts
in past quarter
Heat Score 19
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Orakl Oncology

CB Rank
24505
Orakl Oncology is a precision oncology company that combines data and biology to bring new drugs to cancer patients.
Founded
obfuscation
PrivateNon-equity Assistance Villejuif, Ile-de-France, France1-10 www.orakl-oncology.com
Biotechnology
Medical
Oncology
Therapeutics

Funding Rounds

Non-equity Assistance
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Orakl Oncology SAS
Operating Status Active
Company Type For Profit
Founders  Diane-Laure Pagès, Fanny Jaulin, Gustave Ronteix
About the Company
Orakl Oncology is dedicated to accelerating drug discovery in oncology using advanced biology and AI-powered analysis. The company utilizes a distinct collection of patient tumor avatars that integrates both biological and clinical data to enhance cancer treatment options.
Predictions & Insights

Growth Insight

See this Growth Insight
Orakl Oncology is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Product Launches

Products & Services

Tumor Avatar Platform
A platform that creates individualized tumor avatars by integrating cell biology, engineering, and machine learning to model real-life responses to drugs.
Techbio Platform
Integrates biology with clinical and molecular data to help identify new therapeutic targets and predictive biomarkers, aiming to improve oncology drug development.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Non Equity Assistance - Orakl Oncology Logo
Non Equity Assistance - Orakl Oncology
1
obfuscation
Amazon Web ServicesNon-equity Assistance
obfuscation
Non Equity Assistance - Orakl Oncology Logo
Non Equity Assistance - Orakl Oncology
1
obfuscation
Amazon Web ServicesNon-equity Assistance
obfuscation
Non Equity Assistance - Orakl Oncology Logo
Non Equity Assistance - Orakl Oncology
1
obfuscation
Amazon Web ServicesNon-equity Assistance
obfuscation
Non Equity Assistance - Orakl Oncology Logo
Non Equity Assistance - Orakl Oncology
1
obfuscation
Amazon Web ServicesNon-equity Assistance
obfuscation
Non Equity Assistance - Orakl Oncology Logo
Non Equity Assistance - Orakl Oncology
1
obfuscation
Amazon Web ServicesNon-equity Assistance

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Non Equity Assistance - Orakl Oncology Logo
Non Equity Assistance - Orakl Oncology
1
obfuscation
Amazon Web ServicesNon-equity Assistance
obfuscation
Non Equity Assistance - Orakl Oncology Logo
Non Equity Assistance - Orakl Oncology
1
obfuscation
Amazon Web ServicesNon-equity Assistance
obfuscation
Non Equity Assistance - Orakl Oncology Logo
Non Equity Assistance - Orakl Oncology
1
obfuscation
Amazon Web ServicesNon-equity Assistance
obfuscation
Non Equity Assistance - Orakl Oncology Logo
Non Equity Assistance - Orakl Oncology
1
obfuscation
Amazon Web ServicesNon-equity Assistance
obfuscation
Non Equity Assistance - Orakl Oncology Logo
Non Equity Assistance - Orakl Oncology
1
obfuscation
Amazon Web ServicesNon-equity Assistance

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 5

Employee Profiles

News

News and Press

News•Dec 5, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 29, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 9, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 7, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

4,507
-12.02%
 in past month

IT Spend

$42.5KThis year, Orakl Oncology is projected to spend $42.5K on IT, according to Aberdeen.

Active Website Tech Count

2Orakl Oncology is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 100k.
Sub-Organizations
Frequently Asked Questions

Where is Orakl Oncology's headquarters? Orakl Oncology is located in Villejuif, Ile-de-France, France.Who invested in Orakl Oncology? Orakl Oncology has 7 investors including Amazon Web Services and  Bpifrance.When was the last funding round for Orakl Oncology? Orakl Oncology closed its last funding round on
obfuscation
from a Non-equity Assistance round.Who are Orakl Oncology's competitors? Alternatives and possible competitors to Orakl Oncology may include Tempus, Parse Biosciences, and  InSphero.How much funding has Orakl Oncology raised to date? Orakl Oncology has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(d29fb2e 1)
|